Key result
Percutaneous balloon pericardiotomy appears safe for pericardial effusion, though malignant cases average ~1.2 months survival.
Why the study?
Does percutaneous balloon pericardiotomy safely and effectively treat pericardial effusion in patients with malignant and nonmalignant diseases?
Observational (n=26)
Does percutaneous balloon pericardiotomy safely and effectively treat pericardial effusion in patients with malignant and nonmalignant diseases?
Absolute Event Rate: 1.2% vs 48%
p-value: p=< .001
Percutaneous balloon pericardiotomy is a safe and feasible minimally invasive alternative to surgical pericardial window for managing both malignant and nonmalignant pericardial effusions.
No takes yet. Share an insight, caveat, or question.
May warrant consideration in select pericardial effusion cases; leaves open need for randomized trials versus surgery.
Sigusch et al. (2022) conducted an observational in Malignant and nonmalignant pericardial effusion (n=26). Percutaneous balloon pericardiotomy vs. Nonmalignant disease group was evaluated on Mean survival (p=< .001). Percutaneous balloon pericardiotomy was safe and feasible for pericardial effusion, with a mean survival of 1.2 months in malignant cases versus 48.0 months in nonmalignant cases (p < .001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: